Skip to content

Magnesium and TKA Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01945437
Enrollment
60
Registered
2013-09-18
Start date
2014-01-31
Completion date
Unknown
Last updated
2013-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

The hypothesis of this study is that in staged bilateral total knee arthroplasty (TKA, magnesium sulfate administered during the perioperative period of the first TKA may decrease pain after the second TKA. It is known that pain is greater in the second TKA than in the first. Therefore, we compared pain of the second TKA between the magnesium and control groups.

Interventions

DRUGMagnesium Sulfate

The magnesium group receive intravenous magnesium sulfate.

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

American society of anesthesiologist physical status 1 - 2. patients scheduled to undergo staged bilateral TKA

Exclusion criteria

American society of anesthesiologist physical status \>3 \-

Design outcomes

Primary

MeasureTime frameDescription
Painfrom the end of the TKA until 48 hourPain measured with visual analogue scale (VAS)

Secondary

MeasureTime frameDescription
analgesicfrom the end of the TKA until 48 hoursanalgesic consumptions from the end of the TKA until 48 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026